The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Two new technologies: a formulation system for producing lipid nanoparticles and pharmaceutical-grade gelatin.

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

Why drug developers are turning to this technique for rapid detection of replication-competent viruses.

Experts from the Access to Medicine Foundation discuss how to reduce the risk of antimicrobial resistance (AMR) in antibiotic manufacturing.

Clinical trials have improved greatly over the years, but there is still much to be done.

How do we encourage the development of new cell and gene therapies without compromising our ethics?

The Medicine Maker’s all-inclusive advent calendar…

Countries that struggled to acquire COVID-19 vaccines have not forgotten the inequity, and are reminding pharma giants that they shouldn’t either

Experts in the cell and gene therapy space are excited about things to come. After all, these are the pioneers of a burgeoning field of medicine.